• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【药物名称】BIRA-0596

【化学名称】2-(2,6-Dichlorophenylamino)-6,7-dimethyl-8,9-dihydro-1H-imidazo[4,5-h]isoquinolin-9-one

【CA登记号】333455-11-1

【 分 子 式 】C18H14Cl2N4O

【 分 子 量 】373.24448

【开发单位】Boehringer Ingelheim (Originator)

【药理作用】IMMUNOMODULATING AGENTS, Immunosuppressants, Lck Kinase Inhibitors, Src Kinase Inhibitors

合成路线1

Alkylation of (2-cyanophenyl)acetonitrile (I) with iodomethane under phase-transfer conditions leads to the alpha,alpha-dimethyl nitrile (II), which is further cyclized to imide (III) with 90% H2SO4. Subsequent nitration of homophthalimide (III) with HNO3/H2SO4 furnishes (IV) (1). Nitrophthalimide (IV) is reduced to the corresponding amine (V) by hydrogenation in the presence of Pd/C. This is then converted into acetamide (VI) by treatment with Ac2O. A second nitration reaction with cold HNO3 leads to the nitro amide (VII), which is further hydrolyzed with H2SO4 to the nitro amine (VIII). Hydrogenation of (VIII) over PtO2 furnishes diamine (IX). Coupling of (IX) with 2,6-dichlorophenyl isothiocyanate (X) gives thiourea (XI). Ring closure of amino thiourea (XI) to the benzimidazole derivative (XII) is carried out by treatment with DCC in refluxing THF. Partial reduction of the imide function of (XII) with NaBH4 in moist THF affords (XIII). Finally, rearrangement of (XIII) in concentrated H2SO4 at room temperature gives rise to the title compound (1,2).

1 Snow, R.J.; Cardozo, M.G.; Morwick, T.M.; Bussacca, C.A.; Dong, Y.; Eckner, R.J.; Jacober, S.; Jakes, S.; Kapadia, S.; Lukas, S.; Panzenbeck, M.; Peet, G.W.; Peterson, J.D.; Prokopowicz, A.S. III; Sellati, R.; Tolbert, R.M.; Tschantz, M.A.; Moss, N.; Discovery of 2-phenylamino-imidazo[4,5-h]isoquinolin-9-ones: A new class of inhibitors of lck kinase. J Med Chem 2002, 45, 16, 3394.
2 Goldberg, D.; Cardozo, M.G.; Tschantz, M.A.; Moss, N.; Morwick, T.; Prokopowicz, A.S. III; Snow, R.J.; Patel, U.R.; Wang, X.-J.; Hammach, A.; Takahashi, H. (Boehringer Ingelheim Pharmaceuticals Inc.); Heterocyclic cpds. useful as inhibitors of tyrosine kinases. WO 0125238 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 21593 2-(cyanomethyl)benzonitrile 3759-28-2 C9H6N2 详情 详情
(II) 65069 2-(1-cyano-1-methylethyl)benzonitrile C11H10N2 详情 详情
(III) 21594 4,4-dimethyl-1,3(2H,4H)-isoquinolinedione C11H11NO2 详情 详情
(IV) 65072 4,4-dimethyl-7-nitro-1,3(2H,4H)-isoquinolinedione C11H10N2O4 详情 详情
(V) 65071 7-amino-4,4-dimethyl-1,3(2H,4H)-isoquinolinedione C11H12N2O2 详情 详情
(VI) 65070 N-(4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydro-7-isoquinolinyl)acetamide C13H14N2O3 详情 详情
(VII) 65073 N-(4,4-dimethyl-8-nitro-1,3-dioxo-1,2,3,4-tetrahydro-7-isoquinolinyl)acetamide C13H13N3O5 详情 详情
(VIII) 65074 7-amino-4,4-dimethyl-8-nitro-1,3(2H,4H)-isoquinolinedione C11H11N3O4 详情 详情
(IX) 65075 7,8-diamino-4,4-dimethyl-1,3(2H,4H)-isoquinolinedione C11H13N3O2 详情 详情
(X) 52344 2,6-Dichlorophenyl isothiocyanate 6590-95-0 C7H3Cl2NS 详情 详情
(XI) 65077 N-(8-amino-4,4-dimethyl-1,3-dioxo-1,2,3,4-tetrahydro-7-isoquinolinyl)-N'-(2,6-dichlorophenyl)thiourea C18H16Cl2N4O2S 详情 详情
(XII) 65076 2-(2,6-dichloroanilino)-6,6-dimethyl-1H-imidazo[4,5-h]isoquinoline-7,9(6H,8H)-dione C18H14Cl2N4O2 详情 详情
(XIII) 65078 2-(2,6-dichloroanilino)-7-hydroxy-6,6-dimethyl-1,6,7,8-tetrahydro-9H-imidazo[4,5-h]isoquinolin-9-one C18H16Cl2N4O2 详情 详情

合成路线2

In an alternative method, 2,6-dichloro-3-nitrobenzonitrile (I) is heated with ethanolic ammonia in a sealed vessel to produce the 2-amino benzonitrile (II). Subsequent condensation of 2-amino-6-chloro-3-nitrobenzonitrile (II) with ethyl methylacetoacetate (III) in the presence of K2CO3 leads to the aryl methyl acetoacetate ester (IV). Decarboxylation and cyclization of (IV) under acidic conditions then produces isoquinolinone (V). Nitro group reduction in (V) with H2 and Pd/C leads to diamine (VI), which is further coupled with 2,6-dichlorophenyl isothiocyanate (VII), yielding thiourea (VIII). Finally, ring closure of amino thiourea (VIII) with DCC in hot DMF affords the target tricyclic compound (2).

1 Goldberg, D.; Cardozo, M.G.; Tschantz, M.A.; Moss, N.; Morwick, T.; Prokopowicz, A.S. III; Snow, R.J.; Patel, U.R.; Wang, X.-J.; Hammach, A.; Takahashi, H. (Boehringer Ingelheim Pharmaceuticals Inc.); Heterocyclic cpds. useful as inhibitors of tyrosine kinases. WO 0125238 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 52340 2,6-Dichloro-3-nitrobenzonitrile 5866-98-8 C7H2Cl2N2O2 详情 详情
(II) 65079 2-amino-6-chloro-3-nitrobenzonitrile C7H4ClN3O2 详情 详情
(III) 10362 ethyl 2-methyl-3-oxobutanoate; ethyl 2-methylacetoacetate 609-14-3 C7H12O3 详情 详情
(IV) 65080 ethyl 2-(3-amino-2-cyano-4-nitrophenyl)-2-methyl-3-oxobutanoate C14H15N3O5 详情 详情
(V) 65082 8-amino-3,4-dimethyl-7-nitro-1(2H)-isoquinolinone C11H11N3O3 详情 详情
(VI) 65081 7,8-diamino-3,4-dimethyl-1(2H)-isoquinolinone C11H13N3O 详情 详情
(VII) 52344 2,6-Dichlorophenyl isothiocyanate 6590-95-0 C7H3Cl2NS 详情 详情
(VIII) 65083 N-(8-amino-3,4-dimethyl-1-oxo-1,2-dihydro-7-isoquinolinyl)-N'-(2,6-dichlorophenyl)thiourea C18H16Cl2N4OS 详情 详情
Extended Information